American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (3997)
  2. Hematologic Malignancies, Division of (3800)
  3. Center for Hematologic Malignancies (3677)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1341)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (986)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (940)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1255)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (3997)
  2. Hematologic Malignancies, Division of (3800)
  3. Center for Hematologic Malignancies (3677)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1341)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (311)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (62)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5172)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5553)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Initial results of a phase 1 first-in-human study of cemsidomide (CFT7455), a novel MonoDACTM degrader, with dexamethasone in patients with relapsed/refractory multiple myeloma
    Meeting Abstract

    Dhakal, B.; Yee, A. J.; Richardson, P. G.; Ailawadhi, S.; Chhabra, S.; Muchtar, E.; Berdeja, J. G.; Richard, S.; Matous, J.; Shah, U. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Real world evidence of outcomes of patients treated with talquetamab in a heavily pretreated population with multiple myeloma with high exposure to prior BCMA therapies- A report from the IMWG Consortium
    Meeting Abstract

    Janakiram, M.; Tan, C. R.; Popat, R.; Martínez Lopez, J.; Kastritis, E.; Lau, C.; Chng, W. J.; Kapoor, P.; Mian, H.; Hal, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Evaluation of the safety and efficacy of denosumab in patients with multiple myeloma and severe renal impairment; Results from an IMWG Bone Subcommittee study
    Meeting Abstract

    Terpos, E.; Ntanasis-Stathopoulos, I.; Kyriakou, C.; Tan, C. R.; Abildgaard, N.; Delforge, M.; Fantl, D. B. E.; Seehaus, C. M.; Carneiro, E.; João, C.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Infections in patients with relapsed/refractory multiple myeloma in the United States: A real-world analysis
    Meeting Abstract

    Ida, F.; Ramakrishna, B.; Nasserinejad, K.; Radu, A.; Lawo, J. P.; Zhang, X.; Gardiner, D.; Yoon, L.; Dabrowski, E. C.; Shen, J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Daratumumab versus lenalidomide as maintenance therapy in newly diagnosed multiple myeloma- Interim efficacy results of a randomized clinical trial
    Meeting Abstract

    Rajeeve, S.; Derkach, A.; Devlin, S. M.; Santos, J.; Przemielewska, A.; Sood, T.; Maclachlan, K. H.; Hashmi, H.; Tan, C. R.; Korde, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Uncovering the tumor antigen landscape in patients undergoing dendritic cell/myeloma fusion vaccine with lenalidomide maintenance treatment
    Meeting Abstract

    Karagkouni, D.; Cheloni, G.; Nanda, S.; Ma, Y. L.; Wang, S. S.; Katopodi, L. X.; Saldarriaga, I.; Pita-Juarez, Y.; Chung, D. J.; Shah, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Phase 1/2 studies of DZD8586, a non-covalent BBB penetrant LYN/BTK dual inhibitor, in BTK inhibitor resistant chronic lymphocytic Leukemia (CLL) and other B-cell non-Hodgkin lymphoma (B-NHL)
    Meeting Abstract

    Song, Y.; Zhou, K.; Jing, H.; Chong, G.; Wu, J.; Liu, W.; Li, Z.; Jiang, M.; Lan, M.; Ding, K.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Replication stress induces hyper-APOBEC mutagenesis in multiple myeloma
    Meeting Abstract

    Tauro, M.; Panahi, A.; Ziccheddu, B.; Poos, A. M.; Alaoui, A. Y.; Magaletti, D.; Meads, M. B.; Maclachlan, K. H.; Raab, M. S.; Morgan, G.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A multi-center retrospective study on complex karyotype in patients with Richter transformation who received no chemoimmunotherapy for their CLL
    Meeting Abstract

    Miller, C.; Huang, Y.; Allan, J. N.; Bhat, S. A.; Bond, D. A.; Brander, D. M.; Byrd, J. C.; Chavez, J. C.; Chong, E. A.; Danilov, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Clinical outcomes and variability based on baseline cytogenetic risk of patients with MDS treated with hypomethylating agents: An analysis from the International Consortium for MDS (icMDS) validate database
    Meeting Abstract

    Getz, T. M.; Kewan, T.; Bewersdorf, J. P.; Stempel, J. M.; Lanino, L.; Wei, W.; Ali, N. H. A.; Dezern, A. E.; Sekeres, M. A.; Uy, G. L.; more...
    Blood (2024)

    Fulltext@MSK | Save